David L. Ball - Search Results

Year	Number of Results
2002	1
2003	3
2004	4
2005	3
2006	2
2008	1
2009	1
2010	3
2011	1
2012	2
2013	7
2014	7
2015	9
2016	2
2017	1
2018	2
2019	5
2020	2
2021	1
2022	1
2024	0

1

Controversies in the role of radiotherapy in pleural mesothelioma.

Hanna GG, John T, Ball DL. Hanna GG, et al. Among authors: ball dl. Transl Lung Cancer Res. 2021 Apr;10(4):2079-2087. doi: 10.21037/tlcr-20-583. Transl Lung Cancer Res. 2021. PMID: 34012816 Free PMC article. Review.

2

Single Fraction SBRT for Early Stage Lung Cancer-Less is More?

Siva S, Ball DL. Siva S, et al. Among authors: ball dl. Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1085-1087. doi: 10.1016/j.ijrobp.2018.12.041. Epub 2019 Mar 13. Int J Radiat Oncol Biol Phys. 2019. PMID: 30900559 No abstract available.

3

SABR-COMET: a new paradigm of care lights up the twilight of metastatic disease.

Sogono P, Ball DL, Siva S. Sogono P, et al. Among authors: ball dl. Ann Transl Med. 2019 Nov;7(22):615. doi: 10.21037/atm.2019.10.96. Ann Transl Med. 2019. PMID: 31930016 Free PMC article. No abstract available.

4

Treatment of brain metastases in lung cancer: strategies to avoid/reduce late complications of whole brain radiation therapy.

Shaw MG, Ball DL. Shaw MG, et al. Among authors: ball dl. Curr Treat Options Oncol. 2013 Dec;14(4):553-67. doi: 10.1007/s11864-013-0258-0. Curr Treat Options Oncol. 2013. PMID: 24048959 Review.

5

Preoperative chemotherapy for non-small-cell lung cancer.

Hanna GG, Siva S, Plumridge N, Solomon B, Ball DL. Hanna GG, et al. Among authors: ball dl. Lancet. 2014 Jul 19;384(9939):232-3. doi: 10.1016/S0140-6736(14)61208-3. Lancet. 2014. PMID: 25042230 No abstract available.

6

Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases.

Siva S, Jones G, Bressel M, Shaw M, Chander S, Chu J, Plumridge N, Byrne K, Kothari G, Hardcastle N, Gaudreault M, Kron T, Wheeler G, MacManus M, Hanna GG, Ball DL, David S. Siva S, et al. Among authors: ball dl. Int J Radiat Oncol Biol Phys. 2022 Dec 1;114(5):862-870. doi: 10.1016/j.ijrobp.2022.05.034. Epub 2022 Jun 22. Int J Radiat Oncol Biol Phys. 2022. PMID: 35752407

7

The efficacy of PET staging for small-cell lung cancer: a systematic review and cost analysis in the Australian setting.

Ruben JD, Ball DL. Ruben JD, et al. Among authors: ball dl. J Thorac Oncol. 2012 Jun;7(6):1015-20. doi: 10.1097/JTO.0b013e31824fe90a. J Thorac Oncol. 2012. PMID: 22534816 Free article. Review.

8

Risks of using medical record and administrative data for prognostic models.

Alexander M, Evans SM, Wolfe R, Ball DL, Burbury K. Alexander M, et al. Among authors: ball dl. Med J Aust. 2017 Aug 7;207(3):126. doi: 10.5694/mja16.00919. Med J Aust. 2017. PMID: 28764629 No abstract available.

9

Multimodality guidance for accurate bronchoscopic insertion of fiducial markers.

Steinfort DP, Siva S, Kron T, Chee RR, Ruben JD, Ball DL, Irving LB. Steinfort DP, et al. Among authors: ball dl. J Thorac Oncol. 2015 Feb;10(2):324-30. doi: 10.1097/JTO.0000000000000389. J Thorac Oncol. 2015. PMID: 25616177 Free article.

10

Evaluation of an artificial intelligence clinical trial matching system in Australian lung cancer patients.

Alexander M, Solomon B, Ball DL, Sheerin M, Dankwa-Mullan I, Preininger AM, Jackson GP, Herath DM. Alexander M, et al. Among authors: ball dl. JAMIA Open. 2020 May 1;3(2):209-215. doi: 10.1093/jamiaopen/ooaa002. eCollection 2020 Jul. JAMIA Open. 2020. PMID: 32734161 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

51 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year